Join Gold Sponsor BioMarin for an evening reception as they announce their 2023 Golden Ticket winner! They'll be giving away one Golden Ticket award to a deserving company to help further their research at LabCentral! As well as remarks from the BioMarin team, you'll also get to hear from Ke Zhang, CEO of pacDNA in a fireside chat as he discusses how the BioMarin Golden Ticket helped get his company off the ground
Finalists
Cerberus Therapeutics utilizes nanobody-based platform to create novel therapeutics for modulating the immune system.
HarborSite is establishing a novel gene writing platform that enables highly efficient, targeted insertion of therapeutic genes into safe genomic locations in a variety of cellular contexts.
QurCan Therapeutics fosters scientific creativity with pioneering nanotechnologies to accelerate advanced nanomedicines and improve patients’ quality of life. QurCan is focused on the discovery and development of breakthrough therapeutics enabled by its proprietary nanoparticle drug delivery technology called “TERP”.
Featured Speakers
Chieze Ibeneche-Nnewihe, Ph.D
Senior Director, BD & Corporate Strategy, BioMarin
Johannes Fruehauf
Co-Founder & CEO, LabCentral